A. Robidoux

7.5k citations

29 papers · 4.7k indexed · 3 hit papers · h-index 15

Cancer Research top 0.5%
- Breast Cancer Treatment Studies 12
- Cancer Genomics and Diagnostics 5
Oncology top 0.5%
- Cancer Treatment and Pharmacology 7
- HER2/EGFR in Cancer Research 5
Pathology and Forensic Medicine top 0.5%
- Breast Lesions and Carcinomas 4
Surgery top 2%
Radiology, Nuclear Medicine and Imaging top 2%
- Medical Imaging Techniques and Applications 3
Genetics
- BRCA gene mutations in cancer 7
Pulmonary and Respiratory Medicine
- Advanced Breast Cancer Therapies 5

Co-authors: Norman Wolmark Edwin R. Fisher Anatolio B. Cruz Bernard Fisher D. Lawrence Wickerham Richard G. Margolese Arthur P. DeCillis E.P. Mamounas
Cited by: Cancer Research Oncology Pathology and Forensic Medicine
Journals: Journal of Clinical Oncology (8 papers)Cancer Research (6 papers)Clinical Genetics (3 papers)
Partner nations: Canada United States Belgium

In The Last Decade

A. Robidoux

29 papers receiving 4.5k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

1998 Journal of Clinical Oncology
1997 Journal of Clinical Oncology
1988 JNCI Journal of the National Cancer Institute

Peers

Countries citing papers authored by A. Robidoux

Since Specialization

Citations

This map shows the geographic impact of A. Robidoux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Robidoux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Robidoux more than expected).

Fields of papers citing papers by A. Robidoux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Robidoux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Robidoux. The network helps show where A. Robidoux may publish in the future.

Co-authorship network

The 25 scholars most cited alongside A. Robidoux, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Robidoux Line = papers co-authored together A. Robidoux links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Use of the 21-gene Oncotype DX® Breast Recurrence Score™ (RS) assay in the neoadjuvant treatment setting The Breast ·A. Robidoux,Philip Whitmore,Sokolov AV,Melissa C. Stoppler,Calvin Chao	2017	1
2	Abstract PD5-04: NSABP FB-7: A phase II randomized trial evaluating neoadjuvant therapy with weekly paclitaxel (P) plus neratinib (N) or trastuzumab (T) or neratinib and trastuzumab (N+T) followed by doxorubicin and cyclophosphamide (AC) with postoperative T in women with locally advanced HER2-positive breast cancer Cancer Research ·MSc. Daniel Villazón Pírez,A. Robidoux,Élise Clochette,Jame Abraham,Nicla La Verde,Cut Melda Wati Cut Melda Wati,McGann,Lourdes Calvo,Elena Aguirre,Marc Buyse,KL Pogue-Geile,Ashok Srinivasan,Nan Song,Kadek Novayanti Kusuma Dewi,Norman Wolmark	2016	12
3	Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study Breast Cancer Research and Treatment ·Antoinette R. Tan,David Birkett,Priya Rastogi,Samuel A. Jacobs,A. Robidoux,Patrick J. Flynn,Michael P. Thirlwell,Louis Fehrenbacher,Philip J. Stella,Rakesh Goel,Thomas B. Julian,Louise Provencher,Martin J. Bury,千佳子角,Charles E. Geyer,Sandra M. Swain,Eleftherios P. Mamounas,Norman Wolmark	2014	14
4	Screening for BRCA1 and BRCA2 mutations among French‐Canadian breast cancer cases attending an outpatient clinic in Montreal Clinical Genetics ·P Ghadirian,A. Robidoux,Edgard Nassif,G. Martin,Claude Potvin,Érica Patocskai,Rami Younan,de Zárate M,李季,Ian Fladie,Robert E. Royer,SA Narod	2013	12
5	Abstract S3-2: Chemotherapy prolongs survival for isolated local or regional recurrence of breast cancer: The CALOR trial (Chemotherapy as Adjuvant for Locally Recurrent breast cancer; IBCSG 27-02, NSABP B-37, BIG 1-02) Cancer Research ·Stefan Aebi,Shari Gelber,István Láng,María Eugenia Villarreal,A. Robidoux,Marina Gracinda Modesto,玉军张,EP Mamounas,CE Geyer,Rudolf Maibach,RD Gelber,Norman Wolmark,Irene Wapnir	2012	10
6	S2-3: NSABP Protocol B-34: A Clinical Trial Comparing Adjuvant Clodronate vs. Placebo in Early Stage Breast Cancer Patients Receiving Systemic Chemotherapy and/or Tamoxifen or No Therapy – Final Analysis. Cancer Research ·A Vysotskij,María Eugenia Villarreal,BC Lembersky,Louis Fehrenbacher,CI Falkson,Rmadan H Eldamarawy,В М Хакимова,Adam Brufsky,Shaker R. Dakhil,Thomas E. Lad,Luis Báez-Díaz,JR Gralow,A. Robidoux,EA Perez,Ping Zheng,CE Geyer,SM Swain,J. P. Costantino,EP Mamounas,Norman Wolmark	2011	14
7	Results of a multicenter randomized trial to evaluate a survivorship care plan for breast cancer survivors. Journal of Clinical Oncology ·Eva Grunfeld,John D. Shinn,Jim A. Julian,Gregory R. Pond,Elizabeth Maunsell,Amy Folkes,Mee-Kyung Lim,Anil A. Joy,ShiBingYAO,K. I. Pritchard,Geoff Porter,Daniel Rayson,A. Robidoux,Junichi Kitahori,Jonathan Sussman,Louise Provencher,John Wiernikowski,Jeffrey Sisler	2011	5
8	An open-label, phase II study of weekly nab-paclitaxel as first-line therapy for patients (pts) with metastatic breast cancer (MBC): Safety update. Journal of Clinical Oncology ·Hesham All El-Enshasy,Guy Cantin,Jawaid Younus,Lawrence Panasci,Paul Klimo,Kara Laing,Gustavo Gamba Gómez,Wwt Lam,Oscar Rydsjö,A. Robidoux	2010	5
9	The contribution of founder mutations to early‐onset breast cancer in French‐Canadian women Clinical Genetics ·P Ghadirian,A. Robidoux,Ping Zhang,Robert E. Royer,Mohammad R. Akbari,S Zhang,Roberto Ortiz Moya,Maurício Magalhães Costa,G. Martin,Claude Potvin,Érica Patocskai,de Zárate M,Rami Younan,Edgard Nassif,Sylvie Giroux,SA Narod,François Rousseau,William D. Foulkes	2009	27
10	The Contribution of Founder Mutations to Early-Onset Breast Cancer in French-Canadian Women. Cancer Research ·P Ghadirian,A. Robidoux,Robert E. Royer,晴行小久保,Mohammad R. Akbari,S. Zhang,Roberto Ortiz Moya,Margaret S. Deitz,G. Martin,Claude Potvin,Érica Patocskai,de Zárate M,Rami Younan,Edgard Nassif,Sylvie Giroux,Steven A. Narod,William D. Foulkes	2009	3
11	Wage Losses in the Year After Breast Cancer: Extent and Determinants Among Canadian Women JNCI Journal of the National Cancer Institute ·Sophie Lauzier,Elizabeth Maunsell,Mélanie Drolet,Doug Coyle,Nicole Hébert‐Croteau,Jacques Brisson,Benoı̂t Mâsse,Belkacem Abdous,A. Robidoux,J Robert	2008	117
12	Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians Breast Cancer Research and Treatment ·André Nkondjock,A. Robidoux,L. Mindur,Steven A. Narod,P Ghadirian	2006	84
13	Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer Clinical Genetics ·Pierre O. Chappuis,Nancy Hamel,戴迎喜,Jean Deschênes,A. Robidoux,Claude Potvin,Hengjin Cheng,Himani Fnu,P Ghadirian,William D. Foulkes	2001	14
14	Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.breakdown → Journal of Clinical Oncology ·Bernard Fisher,John Bryant,Norman Wolmark,E.P. Mamounas,A Brown,Edwin R. Fisher,D. Lawrence Wickerham,Mirsada Begovič,Arthur P. DeCillis,A. Robidoux,Richard G. Margolese,Anatolio B. Cruz,James L. Hoehn,Alan Lees,N V Dimitrov,Harry D. Bear	1998	1688
15	Metastatic axillary lymph node technetium-99m-MIBI imaging in primary breast cancer. PubMed ·Raymond Taillefer,A. Robidoux,Sophie Turpin,R Lambert,Hengjin Cheng,Jean Léveillé	1998	46
16	Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.breakdown → Journal of Clinical Oncology ·Bernard Fisher,A Brown,E.P. Mamounas,M. Szabolics,A. Robidoux,Richard G. Margolese,Anatolio B. Cruz,Edwin R. Fisher,D. Lawrence Wickerham,Norman Wolmark,Arthur P. DeCillis,James L. Hoehn,Alan Lees,N V Dimitrov	1997	1373
17	Inflammatory breast cancer: what is the appropriate therapy for patients who have a clinical response to induction chemotherapy? PubMed ·George N. Peters,Carl G. Kardinal,A. Robidoux,Gabriel N. Hortobágyi	1995	2
18	Recent trends in the management of breast cancer. 2. Occult breast lesions: when and how to perform a biopsy for mammographic abnormalities. PubMed ·A. Robidoux	1992	1
19	Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02. Journal of Clinical Oncology ·Norman Wolmark,Howard E. Rockette,D. Lawrence Wickerham,Bernard Fisher,Carol Redmond,Edwin R. Fisher,Martin Potvin,R J Davies,Judy Jones,A. Robidoux	1990	173
20	Postoperative Adjuvant Chemotherapy or Radiation Therapy for Rectal Cancer: Results From NSABP Protocol R-011breakdown → JNCI Journal of the National Cancer Institute ·B. Fisher,Norman Wolmark,Howard E. Rockette,Carol Redmond,Melanie Deutsch,D. L. Wickerham,Edwin R. Fisher,Richard Caplan,Judy Jones,H J Lerner,Gordon Gilbert,Mark Feldman,Anatolio B. Cruz,S Legault-Poisson,Marvin J. Wexler,Walter Lawrence,A. Robidoux,(unknown)	1988	754

About A. Robidoux

A. Robidoux is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 29 papers that have together received 4.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (12 papers), BRCA gene mutations in cancer (7 papers), Cancer Treatment and Pharmacology (7 papers), Advanced Breast Cancer Therapies (5 papers), HER2/EGFR in Cancer Research (5 papers), Cancer Genomics and Diagnostics (5 papers), Breast Lesions and Carcinomas (4 papers) and Medical Imaging Techniques and Applications (3 papers). The work is most often cited by research in Cancer Research (2.8k citations), Oncology (2.8k citations) and Pathology and Forensic Medicine (1.7k citations). A. Robidoux has collaborated with scholars based in Canada, United States and Belgium. Frequent co-authors include Norman Wolmark, Edwin R. Fisher, Anatolio B. Cruz, Bernard Fisher, D. Lawrence Wickerham, Richard G. Margolese, Arthur P. DeCillis, E.P. Mamounas, James L. Hoehn and A Brown. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Genetics, JNCI Journal of the National Cancer Institute and Breast Cancer Research and Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact